✨ Medicines Consent and Renewal




NEW ZEALAND GAZETTE, No. 24 β€” 17 MARCH 2016

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Uptravi
Selexipag 200mcg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Excella GmbH, Feucht, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Uptravi
Selexipag 400mcg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Excella GmbH, Feucht, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Uptravi
Selexipag 600mcg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Excella GmbH, Feucht, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Uptravi
Selexipag 800mcg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Excella GmbH, Feucht, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Uptravi
Selexipag 1000mcg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Excella GmbH, Feucht, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Uptravi
Selexipag 1200mcg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Excella GmbH, Feucht, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Uptravi
Selexipag 1400mcg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Excella GmbH, Feucht, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Uptravi
Selexipag 1600mcg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Excella GmbH, Feucht, Germany

Dated this 10th day of March 2016.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2016-go1443

Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 24





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Uptravi Medicines

πŸ₯ Health & Social Welfare
10 March 2016
Medicines, Consent, Distribution, Uptravi, Selexipag
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Renewal of Provisional Consent to the Distribution of a Medicine

πŸ₯ Health & Social Welfare
Medicines, Provisional Consent, Renewal